ADVOCATE SPOTLIGHT: Debra's Thoughts on ASCO

by Debra Merritt, advocate MY JOURNEY WITH CANCER On November 14, 2008 my journey with cancer began with my husband Cliff’s stage IV colon cancer diagnosis. We had lived an amazing life, married as students in college at the age of 20, and were just four days away from our 30th anniversary and six days away from his…  Read More

July 2014 Webinar – The Latest News About CRC Research & Treatment

Learn the latest findings from the American Society of Clinical Oncology (ASCO) conference in May. The latest studies, treatments and developments and how they impact colorectal cancer patients were discussed. PRESENTED BY: Cathy Eng, M.D. Associate Professor, Department of Gastrointestinal (GI) Medical OncologyDr. Cathy Eng is Associate Professor in the Department of Gastrointestinal (GI) Medical Oncology at The University…  Read More

Andi's Highlights on ASCO 2014

by Andi Dwyer, Director of Health Promotion, Fight Colorectal Cancer Working in the cancer prevention and survivorship field for nearly ten years, I was elated to attend my first ASCO.  However, nothing prepared me for the 35,000 people from throughout the world, gathered to unveil the latest in ‘all things’ cancer.  I came in with a notion this…  Read More

You don't have to be a scientist to get involved in research

Remember the feeling of being a young freshman student walking the halls lined with senior lockers? Sweaty palms. Knocking knees. It was intimidating to be surrounded by upper classman. As a cancer survivor, sometimes the research process can feel similar to the “good” ole’ days of high school. Especially if you don’t love chemistry. But as…  Read More

Stage II Colon Cancer – Chemo or No Chemo?

A brief in a running series from 2013 ASCO® conference: Prognostic Tests – to use or not use . . .  or rather  … To treat or not to treat? New studies for stage II colon cancer patients contemplating chemotherapy . by: Nancy Roach One of the toughest decisions for patients with stage II colon cancer is…  Read More

Experts Issue Practice-Changing Advice: Stop giving calcium/magnesium for oxaliplatin-caused neuropathy

For patients getting the common FOLFOX chemotherapy for colorectal cancer, many oncologists add intravenous calcium and magnesium, hoping to decrease the neuropathy (nerve damage) associated with oxaliplatin-based drugs. But this week, experts at the 2013 ASCO meeting (American Society of Clinical Oncology), announced strong evidence that the calcium/magnesium does no good in either preventing or decreasing…  Read More